Related Experiment Video
Updated: Oct 4, 2025

External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
Ritodrine versus salbutamol for external cephalic version.
Gabriel Levin1, Tal Cahan2, Yishay Weill3
1Department of Gynecologic Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel - levin.gaby@gmail.com.
Intramuscular ritodrine significantly improved external cephalic version (ECV) success rates compared to subcutaneous salbutamol. Both beta-agonist tocolytics were safe and acceptable prior to ECV procedures.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Maternal-Fetal Medicine
Background:
- Beta-agonist tocolytics enhance external cephalic version (ECV) success.
- Intramuscular (IM) and subcutaneous (SC) administration routes are understudied compared to IV and oral.
- Comparing IM ritodrine to SC salbutamol prior to ECV is crucial.
Purpose of the Study:
- To compare the efficacy of IM ritodrine versus SC salbutamol for improving ECV success rates.
- To evaluate the safety and acceptability of these administration routes before ECV.
Main Methods:
- Retrospective study of 1202 patients undergoing ECV (2012-2019).
- Groups matched by parity and placental location.
- Comparison of maternal, pregnancy, ECV, and neonatal characteristics.
Main Results:
- IM ritodrine group showed higher ECV success rates (71.7% vs. 63.8%, P=0.003).
- Higher vaginal delivery rates observed in the ritodrine group (70.7% vs. 60.1%, P<0.001).
- Ritodrine independently associated with increased ECV success (aOR 2.1).
Conclusions:
- Intramuscular ritodrine significantly improves ECV success rates compared to SC salbutamol.
- Both IM ritodrine and SC salbutamol are safe and acceptable tocolytic options before ECV.
- Further research into alternative administration routes for tocolytics is warranted.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

